Monthly Archives: March 2016

Better pharmacovigilance through social media

Monitoring conversations on Facebook, Twitter, and patient forums to identify and assess adverse drug reactions (ADRs) is becoming very popular with pharma companies and healthcare organisations providing useful data for strategy development, competitive research and patient segmentation. But what remains

Posted in Patient Safety, Regulation, Technology

Too many mHealth apps, too little verification

Concerns about the safety and reliability of mHealth apps are growing and recent articles in JAMA and JMIR provide evidence to support these concerns. But not everyone believes deeper review and critique of apps is necessary. An ex-Food and Drug Administration deputy commissioner and

Posted in Apps, Design, Functional programming, Regulation, Software Development, Systems Thinking, Technology, Validation